TheraRadar
Landscape → CNS

OCD Clinical Trial Landscape

Data updated: May 20, 2026

84 clinical trials tracked since 2008

OCD is being studied across 84 clinical trials registered since 2008, with 27 programs currently active. The competitive pipeline includes 2 active Phase 3 trials, 15 active Phase 2 trials, and 10 active Phase 1 trials. Top industry sponsors include Vericel Corporation, Biohaven Pharmaceuticals, Inc..

27 active
/
84 total (since 2008)
10
Phase 1 Active
24 total
15
Phase 2 Active
49 total
2
Phase 3 Active
11 total
3
Phase 4 Active
15 total

Top Industry Sponsors

Sorted by active Active Done Failed
Vericel Corporation 1 0 0
Biohaven Pharmaceuticals, Inc. 0 3 0

Featured Phase 3 Trials

NCT03588975 RECRUITING
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Vericel Corporation n=45
NCT03299166 COMPLETED
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
Biohaven Pharmaceuticals, Inc. n=426
NCT04641143 COMPLETED
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Biohaven Pharmaceuticals, Inc. n=456
NCT04693351 COMPLETED
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
Biohaven Pharmaceuticals, Inc. n=589
NCT03348930 COMPLETED
Tolcapone in Obsessive Compulsive Disorder
University of Chicago n=20

+ 6 more Phase 3 trials — see full database below

OCD — Trials Started by Year (last 10 years)

2016
4
2017
4
2018
6
2019
3
2020
4
2021
3
2022
8
2023
3
2024
5
2025
5
2026
4

TheraRadar.com

Full Trial Database

Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.

Top Sponsors (all-time)

Vericel Corporation
1
Biohaven Pharmaceuticals, Inc.
3
Roche
1
Novartis
1
Transcept Pharmaceuticals
1
Orexigen Therapeutics, Inc
1

Active Trials by Phase

Phase 1
10
Phase 2
15
Phase 3
2
Phase 4
3

Enrollment Size Distribution

1-50
54
51-200
21
201-500
3
501-1k
1
1k+
1

All Industry Sponsors

Sorted by active Active Done Failed
Vericel Corporation 1 0 0
Biohaven Pharmaceuticals, Inc. 0 3 0
NCT03588975 RECRUITING
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Vericel Corporation n=45
NCT05659082 ENROLLING BY INVITATION
Ventral Capsulotomy for Intractable OCD
Butler Hospital n=50
NCT03299166 COMPLETED
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
Biohaven Pharmaceuticals, Inc. n=426
NCT04641143 COMPLETED
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Biohaven Pharmaceuticals, Inc. n=456
NCT04693351 COMPLETED
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
Biohaven Pharmaceuticals, Inc. n=589
NCT03348930 COMPLETED
Tolcapone in Obsessive Compulsive Disorder
University of Chicago n=20
NCT01281969 COMPLETED
Intravenous Immunoglobulin for PANDAS
National Institute of Mental Health (NIMH) n=48
NCT01329133 COMPLETED
Deep Brain Stimulation and Obsessive-compulsive Disorder
University Hospital, Bordeaux n=31
NCT01411774 COMPLETED
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
University of South Florida n=142
NCT01807403 COMPLETED
Comparison of DBS Targets in Obsessive-compulsive Disorder
Assistance Publique - Hôpitaux de Paris n=8
NCT01178385 COMPLETED
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
University of South Florida n=45

Full OCD Pipeline

Every sponsor, every trial across Phase 1–4. Sortable, filterable, exportable.

Unlock with Pro

Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only